Clinical pharmacology in the geriatric patient

被引:201
作者
Hilmer, Sarah N. [1 ]
McLachlan, Andrew J.
Le Couteur, David G.
机构
[1] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia
[2] Royal N Shore Hosp, Dept Aged Care, St Leonards, NSW 2065, Australia
[3] Royal N Shore Hosp, Dept Rehabil Med, St Leonards, NSW 2065, Australia
[4] Univ Sydney, St Leonards, NSW 2065, Australia
[5] Concord RG Hosp, CERA, Concord, NSW 2139, Australia
[6] Univ Sydney, Concord, NSW 2139, Australia
[7] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
关键词
adverse drug reactions; clinical pharmacology; evidence-based medicine; geriatric medicine;
D O I
10.1111/j.1472-8206.2007.00473.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Geriatric patients are a subset of older people with multiple comorbidities that usually have significant functional implications. Geriatric patients have impaired homeostasis and wide inter-individual variability. Comprehensive geriatric assessment captures the complexity of the problems that characterize frail older patients and can be used to guide management, including prescribing. Prescribing for geriatric patients requires an understanding of the efficacy of the medication in frail older people, assessment of the risk of adverse drug events, discussion of the harm:benefit ratio with the patient, a decision about the dose regime and careful monitoring of the patient's response. This requires evaluation of evidence from clinical trials, application of the evidence to frail older people through an understanding of changes in pharmacokinetics and pharmacodynamics, and attention to medication management issues. Given that most disease occurs in older people, and that older people are the major recipients of drug therapy in the Western world, increased research and a better evidence base is essential to guide clinicians who manage geriatric patients.
引用
收藏
页码:217 / 230
页数:14
相关论文
共 163 条
[1]  
Abernethy D R, 1990, Clin Geriatr Med, V6, P285
[2]   COMPARISON IN YOUNG AND ELDERLY PATIENTS OF PHARMACODYNAMICS AND DISPOSITION OF LABETALOL IN SYSTEMIC HYPERTENSION [J].
ABERNETHY, DR ;
SCHWARTZ, JB ;
PLACHETKA, JR ;
TODD, EL ;
EGAN, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (08) :697-702
[3]   Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials [J].
Adler, AI .
CLINICAL MEDICINE, 2001, 1 (06) :472-477
[4]   The relationship between number of medications and weight loss or impaired balance in older adults [J].
Agostini, JV ;
Han, L ;
Tinetti, ME .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (10) :1719-1723
[5]   Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement [J].
Anavekar, N ;
Bais, R ;
Carney, S ;
Eris, J ;
Gallagher, M ;
Johnson, D ;
Jones, G ;
Sikaris, K ;
Lonergan, M ;
Ludlow, M ;
Mackie, J ;
Mathew, T ;
May, S ;
McBride, G ;
Meerkin, M ;
Peake, M ;
Power, D ;
Snelling, P ;
Voss, D ;
Walker, R .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 183 (03) :138-+
[6]   Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study [J].
Ancelin, ML ;
Artero, S ;
Portet, F ;
Dupuy, AM ;
Touchon, J ;
Ritchie, K .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7539) :455-458
[7]   Distribution of prescription drug exposures in the elderly: Description and implications [J].
Anderson, G ;
Kerluke, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (08) :929-935
[8]  
Anson Ofra, 2005, Am J Ther, V12, P359, DOI 10.1097/01.mjt.00001= 09849.55405.48
[9]   The epidemiology of serious adverse drug reactions among the elderly [J].
Atkin, PA ;
Veitch, PC ;
Veitch, EM ;
Ogle, SJ .
DRUGS & AGING, 1999, 14 (02) :141-152
[10]   The influence of information provided by patients on the accuracy of medication records [J].
Atkin, PA ;
Stringer, RS ;
Duffy, JB ;
Elion, C ;
Ferraris, CS ;
Misrachi, SR ;
Shenfield, GM .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (02) :85-88